Sindhu Bhaskaran Pillai

Sindhu Bhaskaran Pillai

Active Director Director DIN 07577845
DIN 07577845 First appointment Sep 2016 Primary industry Business Outsourcing
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Sep 2016
Shareholding value •••• Premium profile

About Sindhu Bhaskaran Pillai

Data last updated:

Sindhu Bhaskaran Pillai is a Director at Flex And Oncology Clinical Research Private Limited (since 2019), Director at Genpro Life Sciences India Private Limited (since 2019) and Director at Wynaut Labs Private Limited (since 2026), and holds 2 more current directorships. The companies operate in Business Outsourcing, Service and Professional Services. The 2 current companies with reported revenue have a combined latest revenue of ₹33.38 Cr; the largest is Flex And Oncology Clinical Research Private Limited at ₹33.24 Cr (FY 2025). Earlier, Sindhu Bhaskaran Pillai was a Director at Clap Research Private Limited (from 2016).

DIN 07577845
Primary Designation Director
Industry Business Outsourcing
First Appointment 22 Sep 2016
Oldest Company Age 12 yrs
Largest company Flex And Oncology Clinical Research Private Limited · ₹33.24 Cr (FY 2025)
Combined revenue ₹33.38 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Jul 20192019₹33.24 Cr (FY 2025)Active
Director10 Jan 20192016₹13.6 Lakh (FY 2017)Active
Wynaut Labs Private Limited U62099KL2026PTC100461
Director28 Jan 20262026Active
Designated Partner25 Jun 20252025Active
Director19 Jun 20192014Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Clap Research Private Limited U74999KL2016PTC046868
Director22 Sep 20162016₹1.37 Cr (FY 2021)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Flex And Oncology Clinical Research Private Limited
Katalyst Business Accelerator Services Foundation
Clap Research Private Limited
Genpro Life Sciences India Private Limited
Premium access

Shareholding and investment profile for Sindhu Bhaskaran Pillai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sindhu Bhaskaran Pillai

Sindhu Bhaskaran Pillai currently holds 5 directorships: Flex And Oncology Clinical Research Private Limited (Director, since 04 Jul 2019, revenue ₹33.24 Cr (FY 2025)); Genpro Life Sciences India Private Limited (Director, since 10 Jan 2019, revenue ₹13.6 Lakh (FY 2017)); Wynaut Labs Private Limited (Director, since 28 Jan 2026); Ananthamaya Foods Llp (Designated Partner, since 25 Jun 2025); Katalyst Business Accelerator Services Foundation (Director, since 19 Jun 2019).

Sindhu Bhaskaran Pillai was first appointed on 22 Sep 2016 as Director at Clap Research Private Limited. The most recent appointment on record is 28 Jan 2026 at Wynaut Labs Private Limited.

The 2 current companies of Sindhu Bhaskaran Pillai that report revenue have a combined latest revenue of ₹33.38 Cr: Flex And Oncology Clinical Research Private Limited ₹33.24 Cr (FY 2025); Genpro Life Sciences India Private Limited ₹13.6 Lakh (FY 2017).

Sindhu Bhaskaran Pillai held 1 earlier board appointment: Clap Research Private Limited (Director, from 22 Sep 2016).

The current boards of Sindhu Bhaskaran Pillai's companies include Patricia Bronke Mcnamara (Flex And Oncology Clinical Research Private Limited), Anoop Parameswarakurup Ambika (Genpro Life Sciences India Private Limited), Dev Nandan Anoop (Wynaut Labs Private Limited), Shreyas Sanjay (Ananthamaya Foods Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available